J
Jupiter Neurosciences, Inc. (JUNS)
NCM – Real vaqt narxi. Valyuta: USD
0.33
-0.01 (-1.78%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.33
-0.01 (-1.78%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Jupiter Neurosciences, Inc., klinik bosqichdagi tadqiqot va ishlab chiqish farmatsevtika kompaniyasi, neyro'yallig'lanishni davolash uchun resveratrol platformasi mahsulotlarini ishlab chiqadi. Kompaniya Friedreich ataksiyasi, nerv sistemasiga zarar etkazadigan va harakatlanish buzilishlariga olib keladigan noyob irsiy kasallikni davolash uchun II bosqich sinovlarida bo'lgan JNS101ni va engil kognitiv buzilishlar/erta bosqichdagi Altsgeymer kasalligini davolash uchun II bosqich sinovlarida bo'lgan JNS108ni ishlab chiqadi. Shuningdek, u mukopolisakkaridoz tip 1ni davolash uchun II bosqich sinovlarida bo'lgan JNS102ni va mitoxondrial ensefalopatiya, sut kislotasi kislotaligi va insultga o'xshash epizodlar sindromini davolash uchun II bosqich sinovlarida bo'lgan JNS107ni ishlab chiqishda ishtirok etadi. Bundan tashqari, kompaniya Parkinson kasalligini davolash uchun IIa bosqich sinovlarida bo'lgan JNS115ni ishlab chiqadi. U Parkinson kasalligi bo'lgan shaxslarda resveratrolning (JOTROLTM) xavfsizligi, bardoshliligi va farmakokinetikasini baholash uchun 2a fazali klinik sinovni rivojlantirish uchun Zina Biopharmaceuticals, LLC bilan va uzoq umr ko'rish, qarish va sog'lom hayot davomiyligiga qaratilgan iste'molchilarga yo'naltirilgan oziq-ovqat mahsulotlari qatorini ishlab chiqish uchun Aquanova AG bilan strategik hamkorlikka ega. Kompaniya ilgari Jupiter Orphan Therapeutics, Inc. nomi bilan tanilgan va 2021 yil avgust oyida Jupiter Neurosciences, Inc. nomini olgan. Jupiter Neurosciences, Inc. 2016 yilda ro'yxatdan o'tgan va shtab-kvartirasi Jupiter, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Claes Wahlestedt M.D., Ph.D. | Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer |
| Dr. Marshall Hayward Ph.D. | Co-Founder, Chief Scientific Officer & Director |
| Mr. Alexander Rosen | Co-Founder & Chief Administrative Officer |
| Mr. Christer Rosen | Co-Founder, CEO & Chairman of the Board |
| Mr. Saleem Elmasri CPA | CFO & Secretary |
| Ms. Alison D. Silva MA, MS | President, Chief Business Officer & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-16 | S-3 | forms-3.htm |
| 2026-04-01 | 10-K | form10-k.htm |
| 2026-02-27 | 8-K | form8-k.htm |
| 2026-02-20 | 8-K | form8-k.htm |
| 2026-02-13 | S-8 | forms-8.htm |
| 2025-12-23 | 8-K | form8-k.htm |
| 2025-12-22 | 8-K | form8-k.htm |
| 2025-12-09 | CORRESP | filename1.htm |
| 2025-11-26 | S-1 | forms-1.htm |
| 2025-11-20 | 8-K/A | form8-ka.htm |